MedPath

Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection

Not Applicable
Completed
Conditions
Acute HIV Infection
Interventions
Other: Nucleic Acid Amplification Testing
Registration Number
NCT01434706
Lead Sponsor
University of California, San Diego
Brief Summary

The investigators propose to study the impact of nucleic acid amplification testing (NAT) screening for acute Human Immunodeficiency Virus (HIV) and Hepatitis C (HCV) infections and Less-Sensitive Enzyme linked Immunoassay (LS-EIA) or 'detuned' testing Vironostika, Trinity Biotech BED, or Ortho-Clinical Diagnostic Vistros ECi for early HIV infection in conjunction with routine rapid HIV testing at HIV counseling and testing sites and venues in the San Diego county. The overarching goal of this study is to develop and implement a system to identify, notify and engage into care those individuals with recent HIV infection in order to better define the HIV and Hepatitis C Virus (HCV) epidemics in the San Diego county and to evaluate and characterize HIV transmission dynamics within the San Diego population.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
22607
Inclusion Criteria
  • Persons presenting for HIV testing to Public Health Department HIV testing site.
  • Men and women >13 years of age.
  • Those who are 13 or older and younger than 18 should be an emancipated minor or have consent given by their legal representative.
  • Participants 18 and over must be able to provide written consent.
  • Participants should be available for follow up for a period of at least 2 weeks after enrollment
Exclusion Criteria
  • Refusal to participate.
  • Unable to provide informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Nucleic Acid Amplification TestingNucleic Acid Amplification TestingNucleic Acid Amplification Testing
Primary Outcome Measures
NameTimeMethod
Nucleic Acid Amplification Testing10 minutes

Positive detection of presence of HIV

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Christie's Place

🇺🇸

San Diego, California, United States

San Diego LGBT Community Center

🇺🇸

San Diego, California, United States

UC San Diego Antiviral Research Center

🇺🇸

San Diego, California, United States

UCSD Lead the Way Storefront

🇺🇸

San Diego, California, United States

Family Health Centers of San Diego

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath